FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Recruiting · NCT06405113 · Registry updated 2025-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2025-02-20 | NCT06405113 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changzhou No.2 People's Hospital | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changzhou No.2 People's Hospital | Changzhou | China | 3 |